Acrux Limited (ASX:ACR – Get Rating) insider Donald Brumley acquired 1,455,000 shares of Acrux stock in a transaction that occurred on Thursday, March 9th. The stock was purchased at an average cost of A$0.06 ($0.04) per share, for a total transaction of A$91,665.00 ($61,520.13).
Donald Brumley also recently made the following trade(s):
Get Acrux alerts:- On Wednesday, March 1st, Donald Brumley 138,187 shares of Acrux stock.
Acrux Price Performance
The company has a quick ratio of 2.89, a current ratio of 2.55 and a debt-to-equity ratio of 33.19.
About Acrux
(Get Rating)
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone.
Recommended Stories
- Oracle Has Spoken: Shares Fall 5%
- Just the Catalyst NIO Investors Needed
- FuelCell Energy Gains Traction, Shares Surge
- Solo Brands May Remind Investors Why Cash is King
- Someone Is Buying The Dip In MongoDB
Receive News & Ratings for Acrux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acrux and related companies with MarketBeat.com's FREE daily email newsletter.
